The influence of genetics on cholesterol levels is evident in individuals with mutations in the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene, leading to familial hypercholesterolaemia (FH). The gene discussed is PCSK9; the disease is familial hyperaldosteronism.